Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved a niche for itself.
The Company enjoys a loyal customer base, reflecting its strength as a brand offering superior diagnostic tests and services.
With its widespread operational network, Metropolis offers a comprehensive range of clinical laboratory tests and profiles. These tests and profiles are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
Metropolis plays a pivotal role in raising the bar of diagnostic accuracy, technological equipment, customer experience and research-driven empathetic service in the industry.
The Company’s broad spectrum of services offer around 3,487 clinical laboratory tests and 530 profiles. Various test combinations, specific to a disease or disorder and wellness profiles used for health and fitness screening form a part of the Company’s service profile.
Metropolis has invested in a variety of specialized tests and also adopted several advanced tests and technologies introduced in the global market. As on date, the Company offers 2,799 specialized tests. One of the prime reasons behind the Company’s leading position in the diagnostics industry is its track record of introducing specialized tests.
Dr Sushil Shah
Chairman Emeritus
Metropolis has always been at the forefront in bringing new tests and technologies to the people. our test menu comprised of 3,487 clinical laboratory tests and over 530 test profiles.
Putting our patients first: Delivering reliable
pathology reports
It gives me immense satisfaction to pen down this message as the Chairman of
Metropolis Healthcare Ltd. It has been a long and humbling journey for me
personally to see Metropolis grow as a reputed and trusted pathology brand
all across India and markets in Africa. I started out with a single minded
focus on putting our patients’ first and a relentless pursuit in delivering
accurate results and quality reports.
Our promise to the patient is very simple; reliable pathology reports and for that we walk the extra mile for recheck and reflex at no additional cost to our patients.
Working in tandem with doctors because pathology
matters
More than 70% of medical decisions today are based on diagnostic reports. My
team of doctors is constantly in touch with clinicians, work in tandem and
help them diagnose and make treatment decisions for their patients.
Be it a simple blood sugar test or a complicated molecular genetic test, we
have built in all the capabilities to deliver the absolute best.
Quality: A way of functioning at
Metropolis
Metropolis has a dedicated quality assurance team that works on
accreditations for our various centers. Our Global Reference Laboratory in
Mumbai is accredited by CAP (College of American Pathologists), a reputed
global accreditation board and NABL (National Accreditation Board for
Testing & Calibration Laboratories). To give a perspective to the benefit of
our shareholders, our CAP Proficiency Testing Scores are above 98%
indicating consistently good proficiency.
Metropolis is the only private laboratory to have in-house developed and NABL accredited EQAS program. This program is used to monitor analytical quality of our group labs and 115 group labs is covered currently and is ready for commercial launch for customers.
Warm regards,Dr Sushil ShahChairman Emeritus
Dr Sushil Shah
Chairman Emeritus
Metropolis has always been at the forefront in bringing new tests and technologies to the people. our test menu comprised of 3,487 clinical laboratory tests and over 530 test profiles.
Ms Ameera Shah
Executive Chairperson and Whole-time Director
As one of the country’s leading diagnostic companies, MHL continues building and nurturing its talent. Several employee training and development initiatives are often undertaken. This helps incorporate integrity as a core ingredient of the Company’s work culture.
To begin with, I would like to bring your attention to an Indicator that I have been passionate and relentless about. I am happy to share with you that in FY19, our Net Promoter Score has been on average at 85, which means that 85% of our customers are willing to recommend Metropolis to their family and network. Our Chairman in his note has emphasized on Metropolis’ core vision of putting the patients first and our customer loyalty score is an outcome of this vision.
Moving on to our performance review, we continue to maintain our position in the leaders’ quadrant and are ranked amongst the Top 2 companies in the fast growing Indian diagnostic industry.
Going closer to the patient
FY19 has ended on a positive note for us as the company delivered faster
than industry growth. We are positive on the short and medium term growth
for Metropolis owing to fast paced network expansion, relentless execution,
strong brand and customer first philosophy. We are happy to report a 15.5%
growth in number of patient visits with increase in revenue per patient
(2.1%) and revenue per test (11.2%), which are better than current industry
standards.
Bolstering our growth in the wellness
space
Our wellness initiative ‘TruHealth’ was launched across 36 cities and we are
confident that this will help us bolster our position in the fast growing
wellness segment. It is heartening to see a positive trend of customers
choosing to safeguard their health by undergoing preventive screening and
diagnose conditions before they turn in to complications.
The Metropolis Family
Our people are at the core of everything we do. Our highly experienced
leadership team leads day to day business and operations. Metropolis’ strong
scientific and technical team of over 2000 members is led by a team of 200
doctors and pathologists. Our phlebotomists and home service technicians are
best in class, highly skilled and trained to collect samples in a single
prick and are efficient in drawing samples from infants, small children and
the elderly. We will make continuous efforts to progress on diversity and
inclusion as we move forward.
Yours truly,Ameera ShahExecutive Chairperson and Whole-time Director